't Hart Lab

't Hart Lab

PUBLICATIONS

List of Publications (link to PubMed) >>>

2021

Krzyzanowski, A., Gasper, R., Adihou, H., ’t Hart, P., Waldmann, H., 2021. “Biochemical Investigation of the Interaction of PICln, RioK1 and COPR5 with the PRMT5–MEP50 Complex.” ChemBioChem 22(11):1908–14

‘t Hart, P., Hommen, P., Noisier, A., Krzyzanowski, A., Schüler, D., Porfetye, A.T, Akbarzadeh, M., Vetter, I.R., Adihou, H., Waldmann, H., 2021. “Structure Based Design of Bicyclic Peptide Inhibitors of RbAp48.” Angewandte Chemie International Edition 60(4):1813–20


2019

‘t Hart, P., Openy, J., Krzyzanowski, A., Adihou, H., Waldmann, H., 2019. “Hot-Spot Guided Design of Macrocyclic Inhibitors of the LSD1-CoREST1 Interaction.” Tetrahedron 75(48).


2017

le Paige, U. B., Smits, B., t Hart, P., Lefeber, F., Martin, N.I., van Ingen, H., 2017. “Weak Coupling between Magnetically Inequivalent Spins: The Deceptively Simple, Complicated Spectrum of a13C-Labeled Trimethylated Amine.” Journal of Magnetic Resonance 278:96-103

’t Hart, P., Wood, T.M., Tehrani, K.H.M.E., van Harten, R.M., Śleszyńska, M., Rentero Rebollo, I., Hendrickx, A.P.A., Willems, R.J.L., Breukink, E., Martin, N.I., 2017. “De Novo Identification of Lipid II Binding Lipopeptides with Antibacterial Activity against Vancomycin-Resistant Bacteria.” Chemical Science 8(12):7991–97


2016

Kleijn, L. H. J., Oppedijk, S. F., ‘t Hart, P., van Harten, R.M., Martin-Visscher, L.A., Kemmink, J., Breukink, E., Martin, N.I., 2016. “Total Synthesis of Laspartomycin C and Characterization of Its Antibacterial Mechanism of Action.” Journal of Medicinal Chemistry 59(7):3569–74

’t Hart, P., Oppedijk, S.F., Breukink, E., Martin, N.I., 2016. “New Insights into Nisin’s Antibacterial Mechanism Revealed by Binding Studies with Synthetic Lipid II Analogues.” Biochemistry 55(1):232–37


2015

Koopmans, T., Wood, T.M., ’t Hart, P., Kleijn, L.H.J., Hendrickx, A.P.A., Willems, R.J.L., Breukink, E., Martin, N.I., 2015. “Semisynthetic Lipopeptides Derived from Nisin Display Antibacterial Activity and Lipid II Binding on Par with That of the Parent Compound.” Journal of the American Chemical Society 137(29):9382–89


2014

Mooney, C.A., Johnson, S.A., ’t Hart, P., Quarles van Ufford, L., de Haan, C.A.M., Moret, E.E., Martin. N.I., 2014. “Oseltamivir Analogues Bearing N-Substituted Guanidines as Potent Neuraminidase Inhibitors.” Journal of Medicinal Chemistry 57(7):3154–60

‘t Hart, P., Kleijn, L.H.J., de Bruin, G., Oppedijk, S.F., Kemmink, J., Martin, N.I., 2014. “A Combined Solid- and Solution-Phase Approach Provides Convenient Access to Analogues of the Calcium-Dependent Lipopeptide Antibiotics.” Organic & Biomolecular Chemistry 12(6):913–18


2012

‘t Hart, P.*, Thomas, D.*, Van Ommeren, R., Lakowski, T.M., Frankel, A., Martin, N.I., 2012. “Analogues of the HIV-Tat Peptide Containing Nη-Modified Arginines as Potent Inhibitors of Protein Arginine N-Methyltransferases.” MedChemComm 3(10)


2011

’t Hart, P.*, Lakowski, T.M.*, Thomas, D., Frankel, A., Martin, N.I., 2011. “Peptidic Partial Bisubstrates as Inhibitors of the Protein Arginine N-Methyltransferases.” ChemBioChem 12(9):1427–32


2010

Lakowski, T. M.*, ‘t Hart, P.*, Ahern, C.A., Martin, N.I., Frankel, A. 2010. “Nη-Substituted Arginyl Peptide Inhibitors of Protein Arginine N-Methyltransferases.” ACS Chemical Biology 5(11):1053–63.
*equal contribution

Go to Editor View